Literature DB >> 26545761

[Abscopal responses of local radiotherapy combined with systemic immunotherapy in patients with metastatic solid tumors].

Cédric Panje1, Matthias Guckenberger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26545761     DOI： 10.1007/s00066-015-0921-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  9 in total

1.  Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

Authors:  F Stephen Hodi; Sandra Lee; David F McDermott; Uma N Rao; Lisa H Butterfield; Ahmad A Tarhini; Philip Leming; Igor Puzanov; Donghoon Shin; John M Kirkwood
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

Authors:  Ana P Kiess; Jedd D Wolchok; Christopher A Barker; Michael A Postow; Viviane Tabar; Jason T Huse; Timothy A Chan; Yoshiya Yamada; Kathryn Beal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-05       Impact factor: 7.038

Review 3.  Role of Local Radiation Therapy in Cancer Immunotherapy.

Authors:  Sandra Demaria; Encouse B Golden; Silvia C Formenti
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

4.  Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.

Authors:  Jonathan P S Knisely; James B Yu; Jaclyn Flanigan; Mario Sznol; Harriet M Kluger; Veronica L S Chiang
Journal:  J Neurosurg       Date:  2012-06-15       Impact factor: 5.115

5.  Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

Authors:  Encouse B Golden; Arpit Chhabra; Abraham Chachoua; Sylvia Adams; Martin Donach; Maria Fenton-Kerimian; Kent Friedman; Fabio Ponzo; James S Babb; Judith Goldberg; Sandra Demaria; Silvia C Formenti
Journal:  Lancet Oncol       Date:  2015-06-18       Impact factor: 41.316

Review 6.  Current clinical trials testing combinations of immunotherapy and radiation.

Authors:  Marka Crittenden; Holbrook Kohrt; Ronald Levy; Jennifer Jones; Kevin Camphausen; Adam Dicker; Sandra Demaria; Silvia Formenti
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 7.  Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.

Authors:  Jennifer A Wargo; Alexandre Reuben; Zachary A Cooper; Kevin S Oh; Ryan J Sullivan
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

Review 8.  Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.

Authors:  Udo S Gaipl; Gabriele Multhoff; Heike Scheithauer; Kirsten Lauber; Stefanie Hehlgans; Benjamin Frey; Franz Rödel
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

9.  Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.

Authors:  Christina Twyman-Saint Victor; Andrew J Rech; Amit Maity; Ramesh Rengan; Kristen E Pauken; Erietta Stelekati; Joseph L Benci; Bihui Xu; Hannah Dada; Pamela M Odorizzi; Ramin S Herati; Kathleen D Mansfield; Dana Patsch; Ravi K Amaravadi; Lynn M Schuchter; Hemant Ishwaran; Rosemarie Mick; Daniel A Pryma; Xiaowei Xu; Michael D Feldman; Tara C Gangadhar; Stephen M Hahn; E John Wherry; Robert H Vonderheide; Andy J Minn
Journal:  Nature       Date:  2015-03-09       Impact factor: 49.962
  9 in total
  1 in total

1.  [Not Available].

Authors:  Sebastian Zschaeck; Michael Baumann
Journal:  Strahlenther Onkol       Date:  2016-09       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.